Overview A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps Status: Not yet recruiting Trial end date: 2024-07-31 Target enrollment: Participant gender: Summary This study will evaluate the effect and safety of 611 in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Phase: Phase 2 Details Lead Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.